Gimme Care vs Ro
Gimme Care costs $19 less a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Gimme Care
Best for: semaglutide at $130/month, 39% below the typical price
Visit Gimme Care →
Ro
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Visit Ro →If you are choosing between Gimme Care and Ro, the first difference is cost: Gimme Care is $19 a month cheaper at the entry price. Gimme Care leads our six-part score, 8.7 to 6.7.
Gimme Care vs Ro price
Gimme Care is the cheaper way in: $130 a month against $149 a month at Ro. That is $19 less each month (13% lower), or about $228 over a year of treatment.
Medications and formats
Gimme Care and Ro do not overlap on medication; only Gimme Care lists semaglutide and tirzepatide; only Ro lists orforglipron.
On format, Gimme Care prices compounded injections, while Ro prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Ro is the only one of the two with a brand-name price.
Where each one treats patients
Gimme Care lists 51 states, and Ro does not publish where it ships.
Pricing
Gimme Care
Ro
Additional membership fees apply
What each price covers
Both prices cover the clinician visit.
Gimme Care's price also covers the medication itself and shipping, which Ro does not claim.
Ro's price also covers lab work and coaching, which Gimme Care does not claim.
Gimme Care is silent on lab work and coaching.
Ro is silent on shipping.
That matters most for the drug: unless Ro confirms otherwise, budget for medication on top of its listed price.
Gimme Care
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Ro
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, Gimme Care scores 8.7 and Ro 6.7 out of 10.
Gimme Care is stronger on value (8.1 vs 5.0), effectiveness (10.0 vs 8.0), trust & safety (8.5 vs 8.0), accessibility (10.0 vs 5.0) and support (7.0 vs 5.5).
User experience is within half a point.
Gimme Care
8.7/10
Ro
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Gimme Care nor Ro has an FDA warning letter on record with us.
Features & Coverage
| Feature | Gimme Care | Ro |
|---|---|---|
| Starting Price | ✓$130/mo | $149/mo |
| Features | 5 features | ✓7 features |
| States Available | 51 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Gimme Care
Gimme Care sells compounded semaglutide at $130-$160/mo and compounded tirzepatide at $163-$199/mo, microdose options included. It is LegitScript verified, available in all 50 states plus DC, with no membership fees.
Read our full Gimme Care review →About Ro
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Read our full Ro review →Pros & Cons
Gimme Care
What we like
- Semaglutide costs $130 a month, 29% below the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $163 a month, 35% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Gimme Care
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Ro
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits, lab work and coaching
- Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Ro
Watch-outs
- Not included in the monthly price: medication
- Confirm it serves your state before you start the intake
Our Verdict
Gimme Care wins this one, 8.7 to 6.7, above all for semaglutide at $130/month, 39% below the typical price. It also costs $19 less each month than Ro. Ro fits better if knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC is your priority.
Choose Gimme Care if…
You want semaglutide at $130/month, 39% below the typical price and an opening price near $130 a month.
Choose Ro if…
You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Gimme Care vs Ro: FAQ
Close alternatives to Gimme Care and Ro
- Gimme Care vs Bioverse
- Gimme Care vs Alternate Health Club
- Gimme Care vs DoctorAdam
- Gimme Care vs Longevixx
- Ro vs Amazon One Medical
- Ro vs LillyDirect Foundayo
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.